Viewing Study NCT05968768


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-31 @ 1:15 AM
Study NCT ID: NCT05968768
Status: RECRUITING
Last Update Posted: 2025-04-10
First Post: 2023-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Sponsor:
Organization: